CervoMed Statistics
Share Statistics
CervoMed has 8.25M shares outstanding. The number of shares has increased by 304.71% in one year.
| Shares Outstanding | 8.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.35M |
| Failed to Deliver (FTD) Shares | 27.64K |
| FTD / Avg. Volume | 8.83% |
Short Selling Information
The latest short interest is 1.48M, so 17.96% of the outstanding shares have been sold short.
| Short Interest | 1.48M |
| Short % of Shares Out | 17.96% |
| Short % of Float | 27.71% |
| Short Ratio (days to cover) | 18.85 |
Valuation Ratios
The PE ratio is -9.35 and the forward PE ratio is -4.66.
| PE Ratio | -9.35 |
| Forward PE | -4.66 |
| PS Ratio | 2.84 |
| Forward PS | 4.3 |
| PB Ratio | 2.75 |
| P/FCF Ratio | -2.73 |
| PEG Ratio | n/a |
Enterprise Valuation
CervoMed Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 3.84, with a Debt / Equity ratio of 0.
| Current Ratio | 3.84 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.29% and return on capital (ROIC) is -105.91%.
| Return on Equity (ROE) | -0.29% |
| Return on Assets (ROA) | -0.22% |
| Return on Capital (ROIC) | -105.91% |
| Revenue Per Employee | 893.11K |
| Profits Per Employee | -271.48K |
| Employee Count | 8 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -77.56% in the last 52 weeks. The beta is 0, so CervoMed 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -77.56% |
| 50-Day Moving Average | 11.36 |
| 200-Day Moving Average | 16.77 |
| Relative Strength Index (RSI) | 24.14 |
| Average Volume (20 Days) | 312.89K |
Income Statement
In the last 12 months, CervoMed had revenue of $7.14M and earned -$2.17M in profits. Earnings per share was $-0.82.
| Revenue | 7.14M |
| Gross Profit | -1.29M |
| Operating Income | -7.81M |
| Net Income | -2.17M |
| EBITDA | -2.17M |
| EBIT | -7.81M |
| Earnings Per Share (EPS) | -0.82 |
Balance Sheet
The company has $7.79M in cash and $0 in debt, giving a net cash position of $7.79M.
| Cash & Cash Equivalents | 7.79M |
| Total Debt | 0 |
| Net Cash | 7.79M |
| Retained Earnings | -54.44M |
| Total Assets | 48.88M |
| Working Capital | 45.56M |
Cash Flow
In the last 12 months, operating cash flow was -$7.45M and capital expenditures -$3, giving a free cash flow of -$7.45M.
| Operating Cash Flow | -7.45M |
| Capital Expenditures | -3 |
| Free Cash Flow | -7.45M |
| FCF Per Share | -2.8 |
Margins
Gross margin is -18.11%, with operating and profit margins of -109.35% and -30.4%.
| Gross Margin | -18.11% |
| Operating Margin | -109.35% |
| Pretax Margin | -30.4% |
| Profit Margin | -30.4% |
| EBITDA Margin | -30.4% |
| EBIT Margin | -109.35% |
| FCF Margin | -104.27% |
Dividends & Yields
CRVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -42.93% |
| FCF Yield | -47.26% |
Analyst Forecast
The average price target for CRVO is $42, which is 2099% higher than the current price. The consensus rating is "Buy".
| Price Target | $42 |
| Price Target Difference | 2099% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 2:3.
| Last Split Date | Aug 17, 2023 |
| Split Type | backward |
| Split Ratio | 2:3 |
Scores
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 3 |